NDC 11673-295 - Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-295
- Package NDCs from labels
- 11673-295-03
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2024-08-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Target Daytime Cold & Flu and Nighttime Severe Cold & Flu Liquid | TARGET CORPORATION | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2024-08-22 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-295-03 | Maximum Strength Daytime Cold and Flu and Nighttime Severe Cold and Flu | 180 mL in 1 BOTTLE | SOLUTION | 180 mL | 650 mg in 20mL | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-295 | MAXIMUM STRENGTH DAYTIME COLD AND FLU AND NIGHTTIME SEVERE COLD AND FLU (ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE, AND ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE,TRIPROLIDINE HYDROCHLORIDE) KIT [TARGET CORPORATION] | 3 | Unmatched | 20240823_0fc523ce-55a7-6384-e063-6394a90aad3f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Advil Sinus Congestion and Pain Relief | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | 531abadc-37fd-4953-95bc-a211a2ba6914 | 2023-03-15 | Warnings | 04JA59TNSJ |
| GUAIFENESIN - ODAAT 1200 MG | GUAIFENESIN | LODAAT LLC | f61d3ae0-11eb-2a82-e053-2995a90a95da | 2023-03-04 | Warnings | 495W7451VQ |
| Insulin Diluting Medium for NovoLog | WATER INJECTION | Novo Nordisk | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 2023-02-28 | Warnings, Adverse reactions | 059QF0KO0R |
| basic care migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amazon.com Services LLC | edcc7b4b-1317-4060-b947-8c16effc5742 | 2023-02-27 | Warnings | 362O9ITL9D |
| CitriDrops | ASCORBICUM ACIDUM, CITRUS LIMONUN, PULSATILLA, SINAPIS NIGRA, LUFFA OPERCULATA, BERBERIS VULGARIS, EUPHORBIUM OFFICINARUM, GUAIACUM, HEPAR SULPHURIS CALCAREUM, MERCURIUS SULPHURATU RUBER | Micro Balance Health Products | f529aef5-ed57-7b26-e053-2995a90a5430 | 2023-02-20 | Warnings | PQ6CK8PD0R |
| triCitrasol | TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 64e7652c-1437-43bd-8ea2-3cafab447b8c | 2023-02-14 | Warnings, Adverse reactions | B22547B95K |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL B22547B95K |
| Acetaminophen | ACETAMINOPHEN | Solupharm Pharmazeutische Erzeugnisse GmbH | adeebc6c-c82f-40dc-b813-1b02244984ce | 2023-02-13 | Warnings, Adverse reactions | 362O9ITL9D |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Granules Pharmaceuticals Inc. | 74e27dab-9790-47e4-b4f1-3b9df4bce184 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| mucus | GUAIFENESIN | CVS Pharmacy | d6f1889e-8228-4c8c-a0e9-6c2afdc07e99 | 2023-01-25 | Warnings | 495W7451VQ |
| MUCUS RELIEF | GUAIFENESIN | KROGER COMPANY | 813b1db2-a177-77c6-e053-2a91aa0ac73b | 2023-01-17 | Warnings | M012 495W7451VQ |
| MUCUS RELIEF DM | DEXTROMETHORPHAN HBR/GUAIFENESIN | KROGER COMPANY | 813baf42-edb0-33a9-e053-2a91aa0a8599 | 2023-01-17 | Warnings | M012 9D2RTI9KYH 495W7451VQ |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS | ab40b62b-9f8d-4394-92d5-09d9f1941eaa | 2023-01-16 | Warnings, Adverse reactions | OJ245FE5EU |
| Daytime Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL AND ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | H-E-B | db19b8c7-0334-0664-e053-2a95a90ad61f | 2023-01-14 | Warnings | M012 |
| Nightime | ACETAMINOPHEN DEXTROMETHORPHAN HBR DOXYLAMINE SUCCINATE | H-E-B | db44560b-da02-74c9-e053-2a95a90af0b6 | 2023-01-13 | Warnings | M012 9D2RTI9KYH 362O9ITL9D |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 6DC9Q167V3 |
| Metab | ASCORBICUM ACIDUM, CYSTEINUM, MANGANESE GLUCONATE, ALPHA-KETOGLUTARICUM ACIDUM, FUMARICUM ACIDUM, GERMANIUM SESQUIOXIDE, IODIUM, MAGNESIUM METALLICUM, NATRUM OXALACETICUM, PULSATILLA (PRATENSIS), THYROIDINUM (SUIS), VANADIUM METALLICUM | Deseret Biologicals, Inc | fbf89a37-dca2-4498-8866-234b033c5d42 | 2023-01-12 | Warnings | PQ6CK8PD0R |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FSA STORE INC. | ec6b7017-cf12-09a7-e053-2995a90a2db9 | 2023-01-12 | Warnings | 362O9ITL9D |
| Mucus Relief | GUAIFENESIN | FSA STORE INC. | ec6b5d2f-6568-08d8-e053-2995a90a4d4b | 2023-01-12 | Warnings | 495W7451VQ |
| CitriPlus | JUGLANS REGIA WHOLE AND ANHYDROUS CITRIC ACID | PEKANA Natuheilmittel GmbH | 11db1b5b-2959-42c4-a059-25c951933004 | 2023-01-11 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.